Citigroup’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$174K Sell
60,391
-94,373
-61% -$372K ﹤0.01% 4061
2025
Q4
$630K Buy
154,764
+70,047
+83% +$314K ﹤0.01% 3447
2025
Q3
$301K Sell
84,717
-76,844
-48% -$278K ﹤0.01% 3811
2025
Q2
$441K Sell
161,561
-153,008
-49% -$316K ﹤0.01% 3701
2025
Q1
$528K Buy
314,569
+47,059
+18% +$132K ﹤0.01% 3645
2024
Q4
$436K Buy
267,510
+162,365
+154% +$484K ﹤0.01% 3927
2024
Q3
$437K Sell
105,145
-250,183
-70% -$1.31M ﹤0.01% 3806
2024
Q2
$1.94M Sell
355,328
-114,342
-24% -$911K ﹤0.01% 2376
2024
Q1
$4.7M Buy
469,670
+279,770
+147% +$2.1M 0.01% 1757
2023
Q4
$775K Buy
189,900
+44,530
+31% +$164K ﹤0.01% 3055
2023
Q3
$563K Buy
145,370
+13,616
+10% +$73.2K ﹤0.01% 2973
2023
Q2
$785K Sell
131,754
-207,016
-61% -$1.19M ﹤0.01% 3021
2023
Q1
$1.11M Buy
338,770
+99,251
+41% +$397K ﹤0.01% 2460
2022
Q4
$946K Sell
239,519
-165,271
-41% -$808K ﹤0.01% 2649
2022
Q3
$2.43M Buy
404,790
+10,540
+3% +$76.1K ﹤0.01% 2010
2022
Q2
$2.54M Buy
394,250
+298,508
+312% +$1.9M ﹤0.01% 1945
2022
Q1
$791K Sell
95,742
-95,521
-50% -$772K ﹤0.01% 3166
2021
Q4
$2.96M Buy
191,263
+136,687
+250% +$2.64M ﹤0.01% 2277
2021
Q3
$1.23M Sell
54,576
-95,630
-64% -$2.01M ﹤0.01% 2933
2021
Q2
$2.95M Buy
150,206
+147,835
+6,235% +$3.35M ﹤0.01% 2359
2021
Q1
$79K Buy
+2,371
New +$77.2K ﹤0.01% 4475

Other funds holding SANA